Related references
Note: Only part of the references are listed.Clinician's Guide to Cardiopulmonary Exercise Testing in Adults A Scientific Statement From the American Heart Association
Gary J. Balady et al.
CIRCULATION (2010)
Intranasal Administration of Adjuvant-Combined Vaccine Protects Monkeys From Challenge With the Highly Pathogenic Influenza A H5N1 Virus
Takeshi Ichinohe et al.
JOURNAL OF MEDICAL VIROLOGY (2010)
Lipid-based delivery of CpG oligonucleotides enhances immunotherapeutic efficacy
Kaley D. Wilson et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Ampligen: A potential toll-like 3 receptor adjuvant for immunotherapy of cancer
B. Jasani et al.
VACCINE (2009)
Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis
Jonathan R. Kerr et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Seven genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis: a detailed analysis of gene networks and clinical phenotypes
J. R. Kerr et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine
Takeshi Ichinohe et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
TLR3 is essential for the induction of protective immunity against Punta Toro virus infection by the double-stranded RNA (dsRNA), poly(I:C12U), but not poly(I:C):: Differential, recognition of synthetic dsRNA molecules
Brian B. Gowen et al.
JOURNAL OF IMMUNOLOGY (2007)
Reduced levels of oestrogen receptor β mRNA in Swedish patients with chronic fatigue syndrome
Hanna Grans et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Intranasal immunization with H5N1 vaccine plus Poly I : Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge
Takeshi Ichinohe et al.
MICROBES AND INFECTION (2007)
Is human herpesvirus-6 a trigger for chronic fatigue syndrome?
Anthony L. Komaroff
JOURNAL OF CLINICAL VIROLOGY (2006)
TLR signaling
T Kawai et al.
CELL DEATH AND DIFFERENTIATION (2006)
Gene expression correlates of unexplained fatigue
T Whistler et al.
PHARMACOGENOMICS (2006)
Exploration of the gene expression correlates of chronic unexplained fatigue using factor analysis
J Fostel et al.
PHARMACOGENOMICS (2006)
Gene expression profile exploration of a large dataset on chronic fatigue syndrome
H Fang et al.
PHARMACOGENOMICS (2006)
Gene expression profile of empirically delineated classes of unexplained chronic fatigue
L Carmel et al.
PHARMACOGENOMICS (2006)
Identifying illness parameters in fatiguing syndromes using classical projection methods
G Broderick et al.
PHARMACOGENOMICS (2006)
Gene expression profiling in the chronic fatigue syndrome
H Gräns et al.
JOURNAL OF INTERNAL MEDICINE (2005)
Translation of eukaryotic translation initiation factor 4GI (eIF4GI) proceeds from multiple mRNAs containing a novel cap-dependent internal ribosome entry site (IRES) that is active during poliovirus infection
MP Byrd et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina
BR Chaitman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina - A randomized controlled trial
BR Chaitman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Identification of novel expressed sequences, up-regulated in the leucocytes of chronic fatigue syndrome patients
R Powell et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2003)
Chronic fatigue syndrome: A review
N Afari et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Chronic fatigue syndrome - Probable pathogenesis and possible treatments
B Evengard et al.
DRUGS (2002)
A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling
G Geiss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
